Overview: Scrub Typhus IgM IFA TestIntroduction: The Scrub Typhus IgM IFA Test confirms scrub typhus IgM to diagnose active infection, causing fever or fatigue. Following 2023 IDSA guidelines, it uses immunofluorescence assays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected active scrub typhus.
Other Names: Scrub Typhus IgM IFA Assay, Orientia IgM IFA Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Scrub typhus IFA testing began in the 1960s with rickettsial disease research. Immunofluorescence methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Confirms scrub typhus IgM to diagnose active infection, guides treatment, and evaluates patients with fever or fatigue.
Test Parameters: 1. Scrub Typhus IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, fatigue, or scrub typhus exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, fatigue, or history of scrub typhus exposure. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, scrub typhus implications, and risks of sample collection.
Procedural Considerations: Uses indirect immunofluorescence assay (IFA) to confirm scrub typhus IgM antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for active scrub typhus diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or early testing can affect results. Cross-reactivity with other rickettsial infections may reduce specificity.
Clinical Significance: Positive IgM confirms active scrub typhus infection, guiding doxycycline therapy. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Scrub typhus PCR, IgG, or clinical evaluation to confirm active scrub typhus diagnosis.
Test Limitations: Non-specific for certain rickettsial infections; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Scrub Typhus Guidelines, 2023; Clinical Infectious Diseases, Kim DM, 2022.
